Annual Current Liabilities
$5.24 M
-$332.00 K-5.96%
December 31, 2023
Summary
- As of February 7, 2025, ATOS annual total current liabilities is $5.24 million, with the most recent change of -$332.00 thousand (-5.96%) on December 31, 2023.
- During the last 3 years, ATOS annual current liabilities has fallen by -$10.44 million (-66.59%).
- ATOS annual current liabilities is now -66.59% below its all-time high of $15.67 million, reached on December 31, 2020.
Performance
ATOS Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Liabilities
$5.80 M
+$100.00 K+1.76%
September 30, 2024
Summary
- As of February 7, 2025, ATOS quarterly total current liabilities is $5.80 million, with the most recent change of +$100.00 thousand (+1.76%) on September 30, 2024.
- Over the past year, ATOS quarterly current liabilities has increased by +$2.35 million (+68.29%).
- ATOS quarterly current liabilities is now -63.01% below its all-time high of $15.67 million, reached on December 31, 2020.
Performance
ATOS Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
ATOS Current Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -6.0% | +68.3% |
| 3 y3 years | -66.6% | +245.9% |
| 5 y5 years | +79.6% | +245.9% |
ATOS Current Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -6.0% | +67.5% | at high | +149.6% |
| 5 y | 5-year | -66.6% | +295.9% | -63.0% | +538.3% |
| alltime | all time | -66.6% | +504.0% | -63.0% | +5790.2% |
Atossa Therapeutics Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $5.80 M(+1.8%) |
| Jun 2024 | - | $5.70 M(+6.9%) |
| Mar 2024 | - | $5.33 M(+1.8%) |
| Dec 2023 | $5.24 M(-6.0%) | $5.24 M(+52.0%) |
| Sep 2023 | - | $3.44 M(-1.0%) |
| Jun 2023 | - | $3.48 M(+18.1%) |
| Mar 2023 | - | $2.94 M(-47.1%) |
| Dec 2022 | $5.57 M(+78.1%) | $5.57 M(+94.1%) |
| Sep 2022 | - | $2.87 M(-24.4%) |
| Jun 2022 | - | $3.79 M(+63.3%) |
| Mar 2022 | - | $2.32 M(-25.7%) |
| Dec 2021 | $3.13 M(-80.1%) | $3.13 M(+86.5%) |
| Sep 2021 | - | $1.68 M(-6.7%) |
| Jun 2021 | - | $1.80 M(+30.2%) |
| Mar 2021 | - | $1.38 M(-91.2%) |
| Dec 2020 | $15.67 M(+1084.8%) | $15.67 M(+901.1%) |
| Sep 2020 | - | $1.57 M(-14.3%) |
| Jun 2020 | - | $1.83 M(+101.2%) |
| Mar 2020 | - | $908.00 K(-31.4%) |
| Dec 2019 | $1.32 M(-54.6%) | $1.32 M(-15.4%) |
| Sep 2019 | - | $1.56 M(+51.5%) |
| Jun 2019 | - | $1.03 M(-30.7%) |
| Mar 2019 | - | $1.49 M(-48.9%) |
| Dec 2018 | $2.92 M(+137.9%) | $2.92 M(-18.0%) |
| Sep 2018 | - | $3.56 M(+18.1%) |
| Jun 2018 | - | $3.01 M(+317.8%) |
| Mar 2018 | - | $720.70 K(-41.2%) |
| Dec 2017 | $1.23 M | $1.23 M(+14.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2017 | - | $1.07 M(-43.8%) |
| Jun 2017 | - | $1.91 M(+146.0%) |
| Mar 2017 | - | $774.80 K(-26.0%) |
| Dec 2016 | $1.05 M(-58.1%) | $1.05 M(+21.2%) |
| Sep 2016 | - | $863.80 K(-1.2%) |
| Jun 2016 | - | $874.30 K(-34.1%) |
| Mar 2016 | - | $1.33 M(-47.0%) |
| Dec 2015 | $2.50 M(+10.5%) | $2.50 M(-24.0%) |
| Sep 2015 | - | $3.29 M(-3.5%) |
| Jun 2015 | - | $3.41 M(-2.1%) |
| Mar 2015 | - | $3.49 M(+54.0%) |
| Dec 2014 | $2.26 M(+61.5%) | $2.26 M(+47.0%) |
| Sep 2014 | - | $1.54 M(-1.5%) |
| Jun 2014 | - | $1.56 M(+44.5%) |
| Mar 2014 | - | $1.08 M(-22.8%) |
| Dec 2013 | $1.40 M(-15.1%) | $1.40 M(-27.8%) |
| Sep 2013 | - | $1.94 M(+9.5%) |
| Jun 2013 | - | $1.77 M(-8.4%) |
| Mar 2013 | - | $1.94 M(+17.3%) |
| Dec 2012 | $1.65 M(+9.2%) | $1.65 M(-27.9%) |
| Sep 2012 | - | $2.29 M(+63.8%) |
| Jun 2012 | - | $1.40 M(+79.4%) |
| Mar 2012 | - | $779.30 K(-48.5%) |
| Dec 2011 | $1.51 M(+74.4%) | $1.51 M(+8.1%) |
| Sep 2011 | - | $1.40 M(+61.4%) |
| Dec 2010 | $866.90 K | $866.90 K(+55.1%) |
| Sep 2010 | - | $558.90 K(+468.0%) |
| Jun 2010 | - | $98.40 K |
FAQ
- What is Atossa Therapeutics annual total current liabilities?
- What is the all time high annual current liabilities for Atossa Therapeutics?
- What is Atossa Therapeutics annual current liabilities year-on-year change?
- What is Atossa Therapeutics quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Atossa Therapeutics?
- What is Atossa Therapeutics quarterly current liabilities year-on-year change?
What is Atossa Therapeutics annual total current liabilities?
The current annual current liabilities of ATOS is $5.24 M
What is the all time high annual current liabilities for Atossa Therapeutics?
Atossa Therapeutics all-time high annual total current liabilities is $15.67 M
What is Atossa Therapeutics annual current liabilities year-on-year change?
Over the past year, ATOS annual total current liabilities has changed by -$332.00 K (-5.96%)
What is Atossa Therapeutics quarterly total current liabilities?
The current quarterly current liabilities of ATOS is $5.80 M
What is the all time high quarterly current liabilities for Atossa Therapeutics?
Atossa Therapeutics all-time high quarterly total current liabilities is $15.67 M
What is Atossa Therapeutics quarterly current liabilities year-on-year change?
Over the past year, ATOS quarterly total current liabilities has changed by +$2.35 M (+68.29%)